Formulation, characterization and evaluation of cyclodextrin-complexed bendamustine-encapsulated PLGA nanospheres for sustained delivery in cancer treatment.
about
Enhanced oral bioavailability and anticancer efficacy of fisetin by encapsulating as inclusion complex with HPβCD in polymeric nanoparticles.Vitamin D-Loaded Nanostructured Lipid Carrier (NLC): A New Strategy for Enhancing Efficacy of Doxorubicin in Breast Cancer Treatment.Inclusion complexes of bendamustine with β-CD, HP-β-CD and Epi-β-CD: in-vitro and in-vivo evaluation.Host-guest inclusion system of rhein with polyamine-modified β-cyclodextrins: characterization and cytotoxicity.PLGA nanoparticles for the oral delivery of nuciferine: preparation, physicochemical characterization and in vitro/in vivo studies.
P2860
Formulation, characterization and evaluation of cyclodextrin-complexed bendamustine-encapsulated PLGA nanospheres for sustained delivery in cancer treatment.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Formulation, characterization ...... delivery in cancer treatment.
@en
type
label
Formulation, characterization ...... delivery in cancer treatment.
@en
prefLabel
Formulation, characterization ...... delivery in cancer treatment.
@en
P2860
P1476
Formulation, characterization ...... delivery in cancer treatment.
@en
P2093
Amber Vyas
Bina Gidwani
P2860
P304
P356
10.3109/10837450.2014.979945
P577
2014-11-13T00:00:00Z